The results of a landmark trial conducted in part at the Memory and Aging Program at Butler Hospital show that amyloid PET brain scan imaging significantly improves both the accuracy of diagnosis and the subsequent medical management of patients with mild cognitive impairment and dementia.
Memory and Aging Program Director Dr. Stephen Salloway, a study co-author, calls the findings a “game changer” in Alzheimer’s research.
The world’s first participant in an Alzheimer’s prevention study finished his 4 1/2-year clinical trial last month. Here’s what he has to say about the experience.
This new study is currently enrolling people aged 40 – 64 with normal memory or early onset cognitive impairment. The goal is to better understand how and why some people develop this rare form of Alzheimer’s disease.
The Memory and Aging Program at Butler Hospital is a world-wide leader in the fight against Alzheimer's. We are dedicated to developing breakthrough treatments for Alzheimer's disease through cutting-edge research into early detection and treatment.
Our research and future breakthroughs depend on the participation of people with normal memory who may be at risk for dementia and those who are already experiencing memory loss, as well as the support of committed community partners, supporters and volunteers.
Can healthy lifestyle changes help to protect memory and thinking in aging adults who are at risk? We’re looking for people ages 60 – 79 to participate in the U.S. POINTER study to find out.
READ MORE
After spending 25 years caring for Alzheimer’s patients Dr. Daniel Gibbs developed the disease himself. He’s now been living with it for at least 13 years, and he’s on a mission to spread an important message.
READ MORE